Total Payments
$43,652
2024 Payments
$2,176
Companies
41
Transactions
671
Medicare Patients
4,134
Medicare Billing
$303,621
Payment Breakdown by Category
Food & Beverage$13,441 (30.8%)
Other$12,100 (27.7%)
Research$10,852 (24.9%)
Consulting$5,796 (13.3%)
Travel$1,194 (2.7%)
Gifts$190.00 (0.4%)
Education$78.76 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,441 | 655 | 30.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,100 | 4 | 27.7% |
| Unspecified | $10,852 | 2 | 24.9% |
| Consulting Fee | $5,796 | 3 | 13.3% |
| Travel and Lodging | $1,194 | 4 | 2.7% |
| Gift | $190.00 | 1 | 0.4% |
| Education | $78.76 | 2 | 0.2% |
Payments by Type
General
$32,800
669 transactions
Research
$10,852
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $14,844 | 106 | $0 (2024) |
| Eli Lilly and Company | $10,852 | 2 | $0 (2019) |
| Allergan, Inc. | $7,845 | 36 | $0 (2022) |
| ABBVIE INC. | $2,405 | 108 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,450 | 76 | $0 (2024) |
| GENZYME CORPORATION | $947.68 | 44 | $0 (2024) |
| Janssen Biotech, Inc. | $844.57 | 57 | $0 (2024) |
| Lilly USA, LLC | $727.81 | 48 | $0 (2024) |
| UCB, Inc. | $643.89 | 32 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $556.21 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,176 | 99 | ABBVIE INC. ($471.98) |
| 2023 | $1,854 | 88 | ABBVIE INC. ($604.45) |
| 2022 | $2,147 | 108 | ABBVIE INC. ($583.05) |
| 2021 | $1,528 | 75 | Galderma Laboratories, L.P. ($338.30) |
| 2020 | $9,864 | 56 | Galderma Laboratories, L.P. ($6,745) |
| 2019 | $3,146 | 80 | Eli Lilly and Company ($1,638) |
| 2018 | $16,208 | 74 | Eli Lilly and Company ($9,214) |
| 2017 | $6,729 | 91 | Allergan Inc. ($5,240) |
All Payment Transactions
671 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII, TARGRETIN | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: Dermatology | ||||||
| 12/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII, TARGRETIN | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $32.07 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Immunology | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.59 | General |
| Category: Immunology | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.45 | General |
| Category: Immunology | ||||||
| 11/08/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $12.48 | General |
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $109.75 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.03 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $26.92 | General |
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), TARGRETIN, DUOBRII | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.30 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.29 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), TARGRETIN, DUOBRII | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A MULTICENTER RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY COMPARING THE EFFICACY AND SAFETY OF LY2439821 TO ETANERCEPT AND PLACEBO IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS | Eli Lilly and Company | $9,214 | 1 |
| A 24-WEEK MULTICENTER, RANDOMIZED, BLINDED, PARALLEL-GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF IXEKIZUMAB TO GUSELKUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS | Eli Lilly and Company | $1,638 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,263 | 3,042 | $178,945 | $89,994 |
| 2022 | 19 | 1,342 | 3,192 | $199,424 | $101,302 |
| 2021 | 15 | 831 | 1,774 | $107,127 | $57,794 |
| 2020 | 10 | 698 | 1,609 | $109,472 | $54,531 |
Total Patients
4,134
Total Services
9,617
Medicare Billing
$303,621
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 269 | 399 | $47,071 | $23,343 | 49.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 233 | 354 | $31,273 | $14,350 | 45.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 58 | 107 | $23,845 | $12,559 | 52.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 111 | 135 | $18,095 | $9,115 | 50.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 155 | 225 | $16,620 | $8,397 | 50.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 199 | 1,507 | $13,245 | $7,364 | 55.6% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 22 | 30 | $7,438 | $3,939 | 53.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 29 | $4,832 | $2,321 | 48.0% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 12 | 19 | $3,649 | $2,166 | 59.4% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2023 | 17 | 23 | $3,037 | $1,553 | 51.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 17 | 17 | $2,543 | $1,267 | 49.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 23 | 33 | $2,193 | $1,214 | 55.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $2,494 | $1,062 | 42.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 20 | 23 | $1,729 | $817.13 | 47.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 21 | $388.29 | $223.01 | 57.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 25 | $125.00 | $117.60 | 94.1% |
| 86580 | Skin test for tuberculosis | Office | 2023 | 17 | 17 | $223.74 | $114.05 | 51.0% |
| J9190 | Injection, fluorouracil, 500 mg | Office | 2023 | 15 | 22 | $88.00 | $39.57 | 45.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 39 | $54.64 | $32.05 | 58.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 303 | 494 | $58,845 | $29,851 | 50.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 246 | 372 | $33,162 | $15,467 | 46.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 68 | 125 | $28,014 | $15,141 | 54.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 105 | 142 | $19,413 | $10,261 | 52.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 210 | 1,499 | $13,461 | $7,512 | 55.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 111 | 146 | $10,848 | $5,848 | 53.9% |
About Dr. Tiffani Hamilton, MD
Dr. Tiffani Hamilton, MD is a Dermatology healthcare provider based in Alpharetta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710931027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tiffani Hamilton, MD has received a total of $43,652 in payments from pharmaceutical and medical device companies, with $2,176 received in 2024. These payments were reported across 671 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($13,441).
As a Medicare-enrolled provider, Hamilton has provided services to 4,134 Medicare beneficiaries, totaling 9,617 services with total Medicare billing of $303,621. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties MOHS-Micrographic Surgery, Dermatopathology
- Location Alpharetta, GA
- Active Since 05/20/2006
- Last Updated 03/09/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1710931027
Products in Payments
- TALTZ (Drug) $11,580
- SKYRIZI (Biological) $1,176
- DUPIXENT (Biological) $1,025
- COSENTYX (Biological) $746.70
- SILIQ (Drug) $537.39
- RINVOQ (Biological) $509.47
- Cimzia (Drug) $496.23
- TREMFYA (Drug) $478.48
- Sotyktu (Drug) $332.09
- Humira (Biological) $241.25
- EUCRISA (Drug) $233.66
- COSENTYX (Drug) $214.68
- BOTOX (Biological) $214.21
- ILUMYA (Biological) $204.68
- BOTOX COSMETIC (Biological) $196.25
- HUMIRA (Biological) $193.55
- DORYX (Drug) $174.82
- XEOMIN (Biological) $149.64
- Tremfya (Drug) $148.80
- Bimzelx (Biological) $147.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Alpharetta
Dr. Chynna Johnson, Md, MD
Dermatology — Payments: $39,387
Dermatology $39,387
Susan Spitzler, Md, MD
Dermatology — Payments: $11,210
Dermatology $11,210
Dr. Emma Murad, M.d, M.D
Dermatology — Payments: $8,210
Dermatology $8,210
Eileen Niren, Md, MD
Dermatology — Payments: $4,496
Dermatology $4,496
Radhika Trivedi, Md; Mph, MD; MPH
Dermatology — Payments: $2,008
Dermatology $2,008
Dr. Anjali Vekaria, Md, MD
Dermatology — Payments: $1,988
Dermatology $1,988